Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

FemPatch approved for marketing in U.S.

Dec. 10, 1996

Benzothiophene compounds for women's health disclosed by Lilly

Dec. 10, 1996

GRF analogs under study at Tulane University

Dec. 10, 1996

New calcimimetic agents from ZymoGenetics

Dec. 9, 1996

Etex signs marketing agreement for bone substitute

Dec. 6, 1996

Successful pivotal Mexican trial for oral impotency therapy

Dec. 6, 1996

Houghten's lead CRA safe in diabetics

Dec. 5, 1996

Priority review for Crinone

Dec. 5, 1996

New nonoxynol-9 formulations tested at University of Kentucky

Dec. 4, 1996

Another Barr generic drug cleared by the FDA

Dec. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...